Furthermore, an immune-mediated liver injury model was established through intravenous injection of Bacillus Calmette-Guérin (BCG) to investigate the dynamic changes in CYP2E1 across different stages of hepatitis and elucidate its regulatory mechanisms. This evidence concerns the gene CYP2E1 and hepatitis A virus infection.